融合三维T1/T2 MRI诊断盆腔深部浸润型子宫内膜异位症的非劣效性研究
本研究以59例疑似子宫内膜异位症的盆腔MRI为对象,由两名不同经验放射科医生随机采用融合三维T1/T2方案与标准方案独立判读,以专家组共识为参考标准。融合三维T1/T2诊断深部浸润型子宫内膜异位症的准确率非劣效于标准方案,判读时间缩短24.5%,读者间一致性提高。
要点
- 融合三维T1/T2诊断深部浸润型子宫内膜异位症的准确率非劣效于标准MRI方案。
- 融合三维T1/T2较标准方案判读时间缩短24.5%(P < 0.001)。
- 融合三维T1/T2读者间一致性为中等(kappa = 0.72),优于标准方案的轻微一致(kappa = 0.47)。
核心结论
- 融合三维T1/T2诊断盆腔深部浸润型子宫内膜异位症的准确率非劣效于当前标准MRI方案,并提高可重复性、缩短判读时间,提示其可能成为诊断盆腔深部浸润型子宫内膜异位症的有价值工具。
研究设计与样本
- 非劣效性研究,纳入59例疑似子宫内膜异位症的盆腔MRI检查,由两名不同经验水平的放射科医生(R#1和R#2)随机采用两种方案独立判读,以专家组共识意见为参考标准,非劣效性界值为2.5%。
诊断标准与关键数值
- 融合三维T1/T2方案诊断深部浸润型子宫内膜异位症的准确率:R#1为94.74%(95%CI: 92.48-96.47),R#2为98.68%(95%CI: 97.31-99.47);标准方案:R#1为92.48%(95%CI: 89.90-94.57),R#2为96.43%(95%CI: 94.48-97.84);非劣效性界值为2.5%。
临床应用与阅片要点
- 融合三维T1/T2方案在保持诊断准确率非劣效的同时,判读时间较标准方案缩短24.5%(P < 0.001),读者间一致性为中等(kappa = 0.72;95%CI: 0.63-0.81),优于标准方案的轻微一致(kappa = 0.47;95%CI: 0.34-0.59)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Magnetic resonance imaging (MRI) is an essential non-invasive technique for diagnosing deep infiltrating endometriosis (DIE). Published studies have explored the value of high-resolution fat-suppressed 3D T1-weighted (T1w) and 3D T2-weighted (T2w) MRI in this topic. However, research on the fusion of these sequences in a merged 'PET-scanner-like' multiplanar reconstruction (Fusion 3D T1/T2) is still lacking. Our primary objective was to assess whether the diagnostic accuracy of Fusion 3D T1/T2 was non-inferior to the state-of-the-art MRI protocol for diagnosing DIE. This standard protocol consists of 2D T2w images in various planes and axial T1w images displayed on a four-window screen (STANDARD). The non-inferiority margin was set at 2.5 %. Fifty-nine pelvic MRI examinations for suspected endometriosis were interpreted independently by two radiologists with different experience levels (R#1 and R#2), randomly with both protocols. Results were compared with a consensus opinion from an expert panel. Interpretation time and inter-reader agreement were also evaluated. Using the Fusion 3D T1/T2 protocol, R#1's diagnostic accuracy for DIE was 94.74% (95%CI: 92.48-96.47) and R#2's was 98.68% (95%CI: 97.31-99.47), both of which were non-inferior to the STANDARD protocol (R#1, 92.48%, 95%CI: 89.90-94.57; R#2, 96.43%, 95%CI: 94.48-97.84). The Fusion 3D T1/T2 protocol reduced interpretation time by 24.5 % (P < 0.001) compared to the STANDARD. Additionally, it improved inter-reader reproducibility, with a moderate level of agreement (kappa = 0.72; 95 % CI: 0.63-0.81), compared to the slight agreement (kappa = 0.47; 95 % CI: 0.34-0.59) observed with the STANDARD protocol. In conclusion, Fusion 3D T1/T2 demonstrated non-inferior diagnostic accuracy compared to the current MRI standard protocol. It also improved reproducibility and reduced interpretation time, suggesting its potential as a valuable tool for diagnosing pelvic DIE.
引用
- Stolz A, Pupulim LF, Soldado MR, et al. Fusion 3D T1/T2 MRI for diagnosing pelvic deep infiltrating endometriosis: a non-inferiority study. Eur J Radiol. 2025. PMID: 40222183. doi:10.1016/j.ejrad.2025.112091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。